FDA (Drugs) recall action 64835
The FDA (Drugs) publishes a recall like this one as 11 separate product records. They share a firm, a date and a cause; this page is all of them in one place, so the scale of the action is visible rather than spread across 11 pages.
Chemical contamination: emission of strong odor after package was opened
Chemical contamination: emission of strong odor after package was opened.
Chemical contamination: emission of strong odor after package was opened..
The agency’s own wording, quoted from the enforcement report.
The unit total adds up the quantities the agency stated for each product. Where a product record gave no figure, or gave a weight rather than a count, it contributes nothing — so the real total is at least this, never less.
Pfizer is recalling Levoxyl (levothyroxine sodium) tablets because they emit a strong odor after the package is opened.
Pfizer is recalling Levoxyl (levothyroxine sodium) tablets because they emit a strong odor after the package is opened.
Pfizer is recalling specific lots of Levoxyl tablets because they emit a strong odor after the package is opened.
Pfizer is recalling specific lots of Levoxyl (levothyroxine sodium) tablets because they emit a strong chemical odor after the package is opened.
Pfizer is recalling specific lots of Levoxyl tablets because they emit a strong odor after the package is opened.
Pfizer is recalling Levoxyl (levothyroxine sodium) tablets because they emit a strong odor after the package is opened.
Pfizer is recalling specific lots of Levoxyl tablets because they emit a strong odor after the package is opened.
Pfizer is recalling specific lots of Levoxyl tablets because they emit a strong odor after opening. The recall covers 10,121 bottles distributed nationwide and in Puerto Rico.
Pfizer is recalling specific lots of Levoxyl tablets because they emit a strong chemical odor after the package is opened.
Pfizer is recalling specific lots of Levoxyl tablets because they emit a strong odor after opening. Consumers should stop using the affected products.
Pfizer is recalling Levoxyl (levothyroxine sodium) tablets because they emit a strong odor after the package is opened.